[Expressions of epithelial growth factor receptor and E-cadherin in esophageal carcinoma and their correlation].
Jian Fu, Da Kuan Yang, Yun Huang, Guo Qiang Hu
Abstract
Jian Fu, Da Kuan Yang, Yun Huang, Guo Qiang Hu
Abstract
BACKGROUND & OBJECTIVE: Up-regulation of epithelial growth factor receptor (EGFR) and down-regulation of E-cadherin are correlated with genesis, progression, invasion, and metastasis of tumor; however,their expressions,especially their association,in esophageal carcinoma have seldom been reported. This study was to detect expressions of EGFR and E-cadherin in esophageal carcinoma, and to analyze their relationship. METHODS: Expressions of EGFR and E-cadherin in 50 specimens of esophageal squamous carcinoma and 8 specimens of esophageal adenocarcinoma were detected by immunohistochemistry. RESULTS: Positive rates of EGFR, and E-cadherin in esophageal squamous carcinoma were 72.0% (36/50), and 22.0% (11/50); while those in esophageal adenocarcinoma were 75.0% (6/8), and 25% (2/8). Positive rates of EGFR in esophageal squamous carcinoma of grades I, II, and III were 63.6%, 75.0%, and 81.3%, respectively. The expression of EGFR negatively correlated with that of E-cadherin (r=-0.341, P=0.008). CONCLUSION: The expression of EGFR in esophageal carcinoma is increased, while that of E-cadherin is decreased;down-regulation of E-cadherin may be associated with up-regulation of EGFR.
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
BACKGROUND & OBJECTIVE: Up-regulation of epithelial growth factor receptor (EGFR) and down-regulation of E-cadherin are correlated with genesis, progression, invasion, and metastasis of tumor; however,their expressions,especially their association,in esophageal carcinoma have seldom been reported. This study was to detect expressions of EGFR and E-cadherin in esophageal carcinoma, and to analyze their relationship. METHODS: Expressions of EGFR and E-cadherin in 50 specimens of esophageal squamous carcinoma and 8 specimens of esophageal adenocarcinoma were detected by immunohistochemistry. RESULTS: Positive rates of EGFR, and E-cadherin in esophageal squamous carcinoma were 72.0% (36/50), and 22.0% (11/50); while those in esophageal adenocarcinoma were 75.0% (6/8), and 25% (2/8). Positive rates of EGFR in esophageal squamous carcinoma of grades I, II, and III were 63.6%, 75.0%, and 81.3%, respectively. The expression of EGFR negatively correlated with that of E-cadherin (r=-0.341, P=0.008). CONCLUSION: The expression of EGFR in esophageal carcinoma is increased, while that of E-cadherin is decreased;down-regulation of E-cadherin may be associated with up-regulation of EGFR.
Key concepts: Cadherin, Epidermal growth factor receptor, Carcinoma, Immunohistochemistry, Adenocarcinoma, Medicine, Squamous carcinoma, Internal medicine